blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1089727

EP1089727 - LIPOSOMAL FORMULATIONS OF BUSULPHAN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.10.2006
Database last updated on 03.09.2024
Most recent event   Tooltip01.08.2008Lapse of the patent in a contracting state
New state(s): LU		published on 03.09.2008  [2008/36]
Applicant(s)For all designated states
Busulipo AB
P.O. Box 5385
102 49 Stockholm / SE
[N/P]
Former [2006/24]For all designated states
Busulipo AB
P.O.Box 5385
10249 Stockholm / SE
Former [2005/11]For all designated states
Hassan, Moustapha, Dr.
Dammvägen 3
141 44 Huddinge / SE
For all designated states
Hassan, Zusana
Dammvägen 3
141 44 Huddinge / SE
Former [2001/15]For all designated states
Karolinska Innovations AB
Box 210
171 77 Stockholm / SE
Inventor(s)01 / HASSAN, Moustapha
Selmedalsvägen 14, 6tr
S-129 36 Hägersten / SE
 [2001/15]
Representative(s)Nyberg, Bengt, et al
BRANN AB
P.O. Box 12246
102 26 Stockholm / SE
[N/P]
Former [2001/15]Nyberg, Bengt, et al
DR. LUDWIG BRANN PATENTBYRA AB, P.O. Box 17192
104 62 Stockholm / SE
Application number, filing date99931721.717.06.1999
[2001/15]
WO1999SE01093
Priority number, dateSE1998000219718.06.1998         Original published format: SE 9802197
US19980089759P18.06.1998         Original published format: US 89759 P
[2001/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9965481
Date:23.12.1999
Language:EN
[1999/51]
Type: A1 Application with search report 
No.:EP1089727
Date:11.04.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 23.12.1999 takes the place of the publication of the European patent application.
[2001/15]
Type: B1 Patent specification 
No.:EP1089727
Date:07.12.2005
Language:EN
[2005/49]
Type: B8 Corrected title page of specification 
No.:EP1089727
Date:08.03.2006
[2006/10]
Search report(s)International search report - published on:SE23.12.1999
ClassificationIPC:A61K31/255, A61K9/127, A61P35/00
[2005/13]
CPC:
A61K31/255 (EP); A61K9/127 (EP); A61P35/00 (EP);
A61P43/00 (EP)
Former IPC [2001/15]A61K31/255, A61K9/127
Designated contracting statesAT,   BE,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LU,   NL,   PT,   SE [2001/15]
TitleGerman:LIPOSOMFORMULATIONEN MIT BUSULPHAN[2001/15]
English:LIPOSOMAL FORMULATIONS OF BUSULPHAN[2001/15]
French:PREPARATIONS A BASE DE BUSULPHAN ENCAPSULEES DANS DES LIPOSOMES[2001/15]
Entry into regional phase29.12.2000National basic fee paid 
29.12.2000Designation fee(s) paid 
29.12.2000Examination fee paid 
Examination procedure05.01.2000Request for preliminary examination filed
International Preliminary Examining Authority: SE
29.12.2000Amendment by applicant (claims and/or description)
29.12.2000Examination requested  [2001/15]
18.09.2003Despatch of a communication from the examining division (Time limit: M06)
12.03.2004Reply to a communication from the examining division
25.03.2004Despatch of a communication from the examining division (Time limit: M02)
10.05.2004Reply to a communication from the examining division
07.03.2005Communication of intention to grant the patent
17.06.2005Fee for grant paid
17.06.2005Fee for publishing/printing paid
Opposition(s)08.09.2006No opposition filed within time limit [2006/46]
Fees paidRenewal fee
19.06.2001Renewal fee patent year 03
20.06.2002Renewal fee patent year 04
18.06.2003Renewal fee patent year 05
21.06.2004Renewal fee patent year 06
21.06.2005Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT07.12.2005
BE07.12.2005
FI07.12.2005
IT07.12.2005
NL07.12.2005
DK07.03.2006
GR07.03.2006
ES18.03.2006
PT08.05.2006
LU17.06.2006
IE19.06.2006
[2008/36]
Former [2008/18]AT07.12.2005
BE07.12.2005
FI07.12.2005
IT07.12.2005
NL07.12.2005
DK07.03.2006
GR07.03.2006
ES18.03.2006
PT08.05.2006
IE19.06.2006
Former [2007/31]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
DK07.03.2006
GR07.03.2006
ES18.03.2006
PT08.05.2006
IE19.06.2006
Former [2007/23]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
DK07.03.2006
GR07.03.2006
ES18.03.2006
PT08.05.2006
Former [2007/02]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
DK07.03.2006
GR07.03.2006
PT08.05.2006
Former [2006/49]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
GR07.03.2006
PT08.05.2006
Former [2006/38]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
GR07.03.2006
Former [2006/36]AT07.12.2005
BE07.12.2005
FI07.12.2005
NL07.12.2005
Former [2006/34]AT07.12.2005
FI07.12.2005
NL07.12.2005
Former [2006/24]FI07.12.2005
NL07.12.2005
Cited inInternational search[X]WO8806442  (LIPOSOME CO INC [US]);
 [X]WO9222298  (UNGER EVAN C [US], et al);
 [X]EP0546951  (LIPOSOME CO INC [US]);
 [A]WO9508991  (UNIV TEXAS [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.